Concepedia

Publication | Open Access

The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

DOIFull Paper Access

57

Citations

16

References

2017

Year

Kazuma Yagi, Makoto Ishii, Ho Namkoong, Takahiro Asami, Osamu Iketani, Takanori Asakura, Shoji Suzuki, Hiroaki Sugiura, Yoshitake Yamada, Tomoyasu Nishimura,
BMC Infectious Diseases

Abstract

Inhaled AMK therapy is an effective and feasible therapy for difficult-to-treat NTM lung disease.

References

YearCitations

Page 1